FundaMental Pharma raised €12.7 million in seed funding, appoints Dr. Dirk Beher as Chief Executive Officer
Apr 11, 2024•over 1 year ago
Amount Raised
€12.7 Million
Round Type
seed
Investors
Novartis Venture Fund
Description
FundaMental Pharma has appointed Dr. Dirk Beher as Chief Executive Officer and Executive Board member, taking over from co-founder Dr. Thomas Schulze. The company recently raised additional seed funding from new investor, the Novartis Venture Fund, bringing its total seed financing to €12.7 million.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech